"England stands at a pivotal moment to transform dementia care, with experts and advocates urging a ‘cancer-style revolution’ to introduce a national 18-week referral-to-treatment target. This urgent call seeks to dismantle a ‘shattered system’ and elevate dementia care to a level playing field with other critical health conditions, demanding significant political will and investment."
A growing consensus among leading health figures, charity organisations, and government ministers is advocating for a transformative overhaul of dementia care in England, spearheaded by the demand for a national waiting-time target. This push, championed by the Alzheimer’s Society and the King’s Trust, proposes an 18-week referral-to-treatment standard, mirroring the successful models implemented for cancer care. The current absence of such a target for dementia stands in stark contrast to other major health conditions, leaving an estimated one million people across the UK, and their families, to navigate a complex and often fragmented system. The urgency of this call is underscored by the projected increase in dementia cases, expected to reach 1.4 million by 2040, demanding immediate and decisive action to modernise support for those living with the disease.
The core of the proposal, articulated in a joint report by the Alzheimer’s Society and the King’s Trust, posits that dementia care is "stuck in the 20th century" and requires a "cancer-style revolution." This metaphor evokes the significant advancements and structured pathways that have been established for cancer patients, including clear diagnostic and treatment targets. The report argues that emulating this success for dementia would not only streamline patient journeys but also ensure timely access to diagnosis, post-diagnostic support, and potential interventions, which are currently severely lacking.
Prominent figures have swiftly backed this initiative. Professor Sir Mike Richards, England’s former national cancer director, who played a pivotal role in introducing cancer waiting-time targets in 2000, has lent his considerable expertise and support. He asserts that an 18-week referral-to-treatment target for dementia patients is entirely "achievable," provided there is the necessary "political initiative" and, crucially, "extra funding." Professor Richards’ experience with the transformative impact of cancer targets highlights the potential for similar positive change in dementia care, driving accountability, resource allocation, and ultimately, improved patient outcomes. He passionately articulates the immense "toll that this condition is taking at the moment, both on the people affected by dementia themselves and their relatives," underscoring the humanitarian and societal imperative for investment.
Further strengthening the call is Baroness Louise Casey, a respected voice in social policy, who is currently leading a major review of adult social care. Baroness Casey has been a vocal proponent of placing dementia on par with other conditions. In a resolute letter to former Health Secretary Wes Streeting in March, she explicitly urged the government to "look at how dementia can be put on a level playing field with other conditions, for example by setting national standards for dementia diagnosis, including an 18-week referral-to-treatment target." Speaking to the BBC, Baroness Casey echoed the sentiment for a "similar mission" to cancer care, stating that society and the National Health Service have "stuck our heads in the sand about it, and it’s time we started saying, yes, we should have a similar mission, and we should do as much as we possibly can on dementia, and now." Her forthcoming recommendations on social care reform, expected next summer, are likely to reinforce these calls for systemic change.
The government, through Social Care Minister Alison McGovern, has expressed support for the direction of travel advocated by the report. In a speech at the Alzheimer’s Society conference, McGovern commended the report as "spot on" in its comparison to the journey undertaken with cancer care. She candidly acknowledged that dementia has been "neglected for far too long" and highlighted the profound impact of the existing systemic failures: "Nowhere is this division between health and social care felt more sharply than by people living with dementia in their families, too often left to navigate a shattered system at the most difficult time in their lives." This ministerial acknowledgement signals a recognition within government of the dire need for reform.
To address these systemic issues, the government has committed to tangible steps. These include the appointment of a senior official, dubbed a "dementia tsar," backed by "real expertise," to oversee dementia care nationally. Furthermore, a new "modern service framework" – essentially a comprehensive plan – is slated for publication by the end of the year, aimed at significantly speeding up support for those living with the disease. While these commitments are welcomed, the true measure of their impact will lie in their implementation and the extent to which they incorporate the specific, measurable targets being advocated.
The discussion around dementia care reform takes on a deeply personal dimension for Prime Minister Andy Burnham. His recent return from compassionate leave following the death of his father, Roy, who had Alzheimer’s disease, has profoundly shaped his perspective. Speaking publicly, Burnham shared that his father would have wanted him "back out there" to enact "the changes that he always pushed me to make." In July, he had previously spoken about his father’s condition and its influence on his determination to reform adult social care in England. This personal experience adds significant weight to the calls for action, though Burnham has stated he will await Baroness Casey’s comprehensive recommendations before making definitive decisions on the specifics of social care reform and its funding mechanisms.
The urgency of this reform is underscored by the escalating demographic challenge. Approximately one million people are currently living with dementia across the UK, a figure projected to rise dramatically to 1.4 million by 2040. This trajectory necessitates a robust, proactive strategy to manage the increasing demand on healthcare and social care systems. The current "shattered system" not only impacts the quality of life for individuals with dementia but also places immense strain on unpaid carers, families, and the wider economy. The "toll" Professor Richards refers to extends beyond individual suffering to encompass the significant economic burden on the NHS, social care services, and lost productivity.
A "cancer-style revolution" for dementia care would entail a multi-faceted approach. It would begin with enhanced public awareness campaigns to reduce stigma and encourage early symptom recognition. Crucially, it would establish clear, rapid diagnostic pathways, ensuring that individuals receive a timely and accurate diagnosis. Beyond diagnosis, the framework would mandate comprehensive post-diagnostic support, including access to information, support groups, practical assistance, and, where appropriate, disease-modifying or symptomatic treatments. The 18-week target would serve as a critical lever to ensure that individuals move efficiently from initial referral to the commencement of this vital package of support.
Implementing such a revolution, however, presents significant challenges. The need for "extra funding" is paramount. This would cover not only the direct costs of faster diagnosis and treatment pathways but also investment in a skilled workforce across primary care, specialist memory services, and social care. Training, recruitment, and retention of staff, from neurologists and geriatricians to specialist nurses and care home workers, would be essential. Furthermore, the infrastructure to support these pathways – including diagnostic facilities, community support services, and digital health records – would require substantial upgrades.
The complexity of dementia itself, with its varied types and progressive nature, also poses unique considerations compared to cancer. While cancer often has clear treatment protocols, dementia management focuses more on symptom management, support, and maintaining quality of life, alongside emerging disease-modifying therapies. Therefore, the "treatment" component of the 18-week target would need to be broadly defined to encompass a comprehensive, individualised care plan rather than solely medical intervention.
In conclusion, the unified call from health experts, charities, and government figures for a national waiting-time target for dementia care represents a critical juncture for England’s health and social care system. The echoes of successful cancer care models provide a compelling blueprint, while the personal experiences of leaders like Prime Minister Burnham underscore the profound human impact of the current system’s failings. Achieving this "cancer-style revolution" will demand not just political will and ministerial commitment, but also substantial investment, a dedicated workforce, and a holistic, integrated approach to care. The stakes are high, with the wellbeing of millions of individuals and the future sustainability of care services hanging in the balance, making this an imperative for the present and future generations.
